White Paper

Lessons Learned In The Rush For A Vaccine And The Effects On Language Translation

Source: TransPerfect

The pandemic has changed society profoundly. The disruption in human and business interactions have not only affected the travel, conference, and hospitality industries but has also changed the clinical research landscape forever.

With the rush for vaccines, we are seeing pharmas and biotechs perform virtual clinical trials, Real World Evidence (RWE), patient visits, study enrollment, and clinical outcome assessments (COAs) almost exclusively virtually. This has accelerated the adoption of electronic patient data capture; both self- and clinician-reported. The rapidity of study startup and necessary documentation required has made clinical services companies address their models and create new technologies to meet the new normal. 

While the pandemic has unleashed on the world never-before-seen challenges, it’s worth noting the positive outcomes as well. Large pharma and biotech companies have collaborated to develop a vaccine in record-breaking time without sacrificing any of the safety protocols prescribed by the notifying bodies. Life science technology vendors have seen a paradigm shift in the adoption of patient data gathered electronically. There is an increased demand for app-based solutions, and those deployed solutions have been updated at a faster rate than ever before seen.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader